100 PARK AVE., 23RD FLOOR, NEW YORK, NY
Changing the Company's Accountant
Material disclosure
Annual Report to Security Holders
Changes in Board, Management or Compensation, Other Events
Provides Regulatory Update on Planned BLA Filing and Future Plans for Iomab-B in the U.S.
Reg. FD
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload